As the COVID-19 pandemic continues to impact global health, researchers are uncovering new risk factors that contribute to severe illness. A recent study conducted by researchers at Washington University School of Medicine in St. Louis sheds light on the relationship between cannabis use and COVID-19 severity. Contrary to popular belief, the study reveals that cannabis use is associated with an increased risk of serious illness for those infected with the virus. Let’s delve into the details of this important finding.
The Study:
The study analyzed health records of 72,501 people who sought care for COVID-19 at health centers within a major Midwestern health-care system during the first two years of the pandemic. Researchers found that individuals who reported using any form of cannabis at least once in the year before developing COVID-19 were significantly more likely to require hospitalization and intensive care than those with no such history. This elevated risk of severe illness was comparable to that observed in smokers.
Context and Implications:
While cannabis use has been widely debated in terms of its health effects, this study highlights the need for further research. The findings challenge the perception that cannabis is harmless and underscore the importance of considering its impact on COVID-19 outcomes. Unlike tobacco smoking, cannabis use did not correlate with increased mortality from COVID-19.
As the world grapples with the ongoing pandemic, understanding risk factors is crucial. The link between cannabis use and COVID-19 severity warrants attention, and health care providers should consider this when assessing patients.
